The utility of remdesivir in SARS-CoV-2: A single tertiary care center experience from a developing country

BACKGROUND: Remdesivir is a monophosphoramidate prodrug of an adenosine analog, and it has a broad-spectrum antiviral activity against paramyxoviruses, flaviviruses, and coronaviruses. Remdesivir is associated with decreased hospital stay and improved outcomes in coronavirus- disease 2019 (COVID-19)...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Muhammad Irfan, Zafar, Sardar Al Fareed, Malik, Muna, Qayyum, Fabiha, Akram, Iqra, Arshad, Ammarah, Waheed, Khalid, Saleem, Jodat, Jabbar, Abdul, Tahir, Muhammad Junaid, Yousaf, Zohaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823973/
https://www.ncbi.nlm.nih.gov/pubmed/35156078
http://dx.doi.org/10.1016/j.rcsop.2022.100107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823973/
https://www.ncbi.nlm.nih.gov/pubmed/35156078
http://dx.doi.org/10.1016/j.rcsop.2022.100107

Ejemplares similares